高级检索
当前位置: 首页 > 详情页

Ocular Features and Mutation Spectrum of Patients With Familial Exudative Vitreoretinopathy.

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Ophthalmology, Peking University People's Hospital Eye diseases and optometry institute, Beijing, China. [2]Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, Beijing, China. [3]College of Optometry, Peking University Health Science Center, Beijing, China. [4]Department of Ophthalmology, Xiamen Eye Center of Xiamen University, Xiamen, China.
出处:
ISSN:

关键词: familial exudative vitreoretinopathy inheritance ocular manifestation retinal vascular development

摘要:
To investigate the clinical findings in Chinese patients diagnosed with familial exudative vitreoretinopathy (FEVR) and carrying pathogenic mutations.One hundred twenty unrelated patients with FEVR were enrolled in this study. Genomic DNA and ophthalmic examinations were collected from all the patients and their available relatives. Targeted next-generation sequencing was performed to detect mutations. In silico programs were used to evaluate the pathogenicity of all the mutations.Eighty identified mutations were found in 81 unrelated patients (31/81 in LRP5, 25/81 in FZD4, 12/81 in TSPAN12, 8/81 in NDP, 4/81 in KIF11, and 1/81 in ZNF408). Among those mutations, 53 were novel (23/35 in LRP5, 15/21 in FZD4, 8/11 in TSPAN12, 3/8 in NDP, 3/4 in KIF11, 1/1 in ZNF408). Patients with LRP5, FZD4, TSPAN12, or NDP mutations were mainly classified into stage 4 and stage 5 and one-half of patients with KIF11 mutations were in stage 4. In addition, all the patients in NDP group were found to have bilateral symmetry in FEVR stage.Our results present profound phenotypic variability and a wide mutation spectrum of FEVR in the Chinese population, which could be useful for a precise and comprehensive genetic diagnosis for patients with FEVR in the future.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 3 区 医学
小类 | 2 区 眼科学
最新[2023]版:
大类 | 2 区 医学
小类 | 2 区 眼科学
第一作者:
第一作者机构: [1]Department of Ophthalmology, Peking University People's Hospital Eye diseases and optometry institute, Beijing, China. [2]Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, Beijing, China. [3]College of Optometry, Peking University Health Science Center, Beijing, China.
通讯作者:
通讯机构: [1]Department of Ophthalmology, Peking University People's Hospital Eye diseases and optometry institute, Beijing, China. [2]Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, Beijing, China. [3]College of Optometry, Peking University Health Science Center, Beijing, China. [*1]Department of Ophthalmology, Peking University People’s Hospital, Eye Diseases and Optometry Institute, Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, College of Optometry, Peking University Health Science Center, 100044 Beijing, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:21710 今日访问量:2 总访问量:1245 更新日期:2025-03-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)